Emails from the Veterans Health Administration released in response to American Oversight's request for communications containing key terms related to Spravato, a drug promoted by President Trump.
FOIA request to the U.S. Department of Veterans Affairs seeking email communications from VA officials regarding the anti-depressant nasal spray Spravato (esketamine), on key dates.